ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World, pp.12-20, 2014. ,
Progress on human papillomavirus (HPV) infection and cervical cancer prevention in sub-Saharan Africa: highlights of the 27th International Papillomavirus Conference in Berlin, J Epidemiol Global Health, vol.2, issue.2, pp.99-102, 2011. ,
Worldwide burden of cervical cancer in 2008, Ann Oncol, vol.22, issue.12, pp.2675-86, 2011. ,
IdowuAjiboye BO. Feasibility, acceptability, and effectiveness of visual inspection of the cervix with acetic acid and cryotherapy for dysplasia in Nigeria ,
, Int J Gynaecol Obstet, vol.129, issue.1, pp.62-68, 2015.
Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania, Afr Health Sci, vol.11, issue.1, pp.48-57, 2011. ,
Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a periurban area in Andhra Pradesh, India. Cancer Epidemiol Biomark Prev, vol.19, issue.5, pp.1373-80, 2010. ,
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, vol.189, issue.1, pp.12-21, 1999. ,
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol, vol.11, issue.11, pp.70230-70238, 2010. ,
Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa, PLoS One, vol.7, issue.9, p.44332, 2012. ,
Cancer Fact sheets, 2012. ,
High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon, J Med Virol, vol.77, issue.3, pp.430-438, 2005. ,
Sequence variations of human papillomavirus type 16 E6 and E7 genes in cervical cancer isolates from Gabon, Br Microbiol Res J, vol.8, issue.2, pp.386-94, 2015. ,
, WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention, 2013.
Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India, Int J Cancer, vol.106, issue.3, pp.404-412, 2003. ,
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments, J Virol, vol.69, issue.12, pp.7743-53, 1995. ,
E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature, Virology, vol.410, issue.1, pp.201-216, 2011. ,
WHO Guidelines for screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention, 2013. ,
Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening, Cancer Causes Control, vol.16, issue.6, pp.657-66, 2005. ,
Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India, Int J Cancer, vol.137, issue.4, pp.859-67, 2015. ,
Interest in visual inspection with acetic acid and Lugol iodine with colposcope in screening of cervical lesions in Gabon, Pan Afr Med J, vol.22, p.165, 2015. ,
Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities, Infectious Agents Cancer, vol.11, issue.2, 2016. ,
Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea Diagn Pathol, vol.4, p.31, 2009. ,
Age-specific prevalence of infection with human papillomavirus in females: a global review, J Adolesc Health, vol.43, issue.4, 2008. ,
Human papillomavirus genotype distribution among Cameroonian women with invasive cervical cancer: a retrospective study, Sex Transm Infect, vol.91, issue.6, pp.440-444, 2015. ,
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems, J Clin Microbiol, vol.35, issue.6, pp.1304-1314, 1997. ,
Improved amplification of genital human papillomaviruses, J Clin Microbiol, vol.38, issue.1, pp.357-61, 2000. ,
Unexpected high prevalence of HPV 90 infection in an underserved population: is it really a low-risk genotype?, Arch Pathol Lab Med, vol.137, issue.11, pp.1569-73, 2013. ,
Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity, PloS One, vol.5, issue.9, 2010. ,
Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection, J Natl Cancer Inst, vol.86, issue.20, pp.1558-1567, 1994. ,
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia, J Gen Virol, vol.81, pp.2959-68, 2000. ,
Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, J Med Virol, 2015. ,
The uganda study on HPV variants and genital cancers, J Clinvirol, vol.19, issue.1-2, pp.31-41, 2000. ,
Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women, BMC Infect Dis, vol.13, p.378, 2013. ,
,
, El Mostafa El Fahime
,
Mohammed Attaleb Molecular Characterization of HPV16 E6 and E7 Variants among Women with Cervical Cancer in Morocco, Br Microbiol Res J, vol.3, issue.4, pp.692-705, 2013. ,
Mutation detection of E6 and LCR genes from HPV 16 associated with carcinogenesis, Asian Pac J Cancer Prev, vol.16, issue.3, pp.1151-1158, 2015. ,
Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India, J Clin Microbiol, vol.46, issue.3, pp.1060-1066, 2008. ,
Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain. PloS One, vol.9, issue.8, p.104678, 2014. ,
Genome variation of human papillomavirus types: phylogenetic and medical implications, Int J Cancer, vol.118, issue.5, pp.1071-1077, 2006. ,